Advertisement
Logo
Search for

Volume 36, Issue 9, Pages 2567-2569 (November 2004)


View previous. 13 of 94 View next.

The impact of total plasma exchange on early allograft dysfunction

C. CamciCorresponding Author Information, M. Akdogan, A. Gurakar, R. Gilcher, J. Rose, R. Monlux, S. Alamain, H. Wright, A. Sebastian, B. Nour

Abstract 

Introduction

Early allograft dysfunction (EAD) is a rare but serious complication encountered among patients undergoing liver transplant surgery. Total plasma exchange (TPE) in EAD has been suggested, but its role is still considered investigational. We retrospectively assessed the efficacy of TPE in EAD and its impact on other parameters of liver function.

Materials and methods

Between 1995 and 2001, 25 orthotopic liver transplant recipients developed EAD, which was defined as early postoperative prothrombin time (PT) >17 seconds, aspartate aminotransferase (AST) and/or alanine aminotransferase (ALT) >2500 IU/L, and/or the presence of hepatic encephalopathy, and development of renal failure. Daily TPE was performed using the Cobe Spectra TPE (Gambro) for 4 hours until an adequate clinical response, the patient underwent retransplantation, or the patient died. International normalizing ratio (INR), partial thromboplastin time (PTT), fibrinogen, ALT, AST, gamma-glutanyl transpeptidase (GGT), blood urea nitrogen (BUN), ammonia, and total bilirubin were analyzed before and after TPE. Student t and chi-square tests were used for statistical analysis.

Results

Twenty-five patients with EAD included 13 females, 12 males of mean age 42.3 years (range, 1–63 years). Coagulopathy and hyperbilirubinemia significantly improved with TPE. Nineteen patients (76%) survived and 2 required retransplantation. Mean number of TPE sessions was 4.3.

Conclusion

TPE was effective to correct coagulopathy and improve liver function. These results suggest the benefit of potential temporary liver support until recovery or retransplantation, in the absence of sepsis or multi-system organ failure.

Integris Baptist Medical Center, and Oklahoma Blood Institute

Corresponding Author InformationAddress reprint requests to C. Camci, Integris Baptist Medical Center

PII: S0041-1345(04)01143-1

doi:10.1016/j.transproceed.2004.09.071


View previous. 13 of 94 View next.

Advertisement